Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers

医学 三阴性乳腺癌 人表皮生长因子受体2 卡铂 内科学 乳腺癌 肿瘤科 三重阴性 癌症研究 表皮生长因子受体 受体 癌症 病理 化疗 顺铂
作者
Carsten Denkert,Gϋnter von Minckwitz,Jan C. Brase,Bruno V. Sinn,Stephan Gade,Ralf Kronenwett,Berit M. Pfitzner,Christoph Salat,Sherene Loi,Wolfgang Schmitt,Christian Schem,Karin Fisch,Silvia Darb‐Esfahani,Keyur Mehta,Christos Sotiriou,Stephan Wienert,Peter Klare,Fabrice André,Frederick Klauschen,Jens‐Uwe Blohmer,Kristin Krappmann,Marcus Schmidt,Hans Tesch,Sherko Kümmel,Hans‐Peter Sinn,Christian Jackisch,Manfred Dietel,Toralf Reimer,Michael Untch,Sibylle Loibl
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:33 (9): 983-991 被引量:945
标识
DOI:10.1200/jco.2014.58.1967
摘要

Purpose Modulation of immunologic interactions in cancer tissue is a promising therapeutic strategy. To investigate the immunogenicity of human epidermal growth factor receptor 2 (HER2) –positive and triple-negative (TN) breast cancers (BCs), we evaluated tumor-infiltrating lymphocytes (TILs) and immunologically relevant genes in the neoadjuvant GeparSixto trial. Patients and Methods GeparSixto investigated the effect of adding carboplatin (Cb) to an anthracycline-plus-taxane combination (PM) on pathologic complete response (pCR). A total of 580 tumors were evaluated before random assignment for stromal TILs and lymphocyte-predominant BC (LPBC). mRNA expression of immune-activating (CXCL9, CCL5, CD8A, CD80, CXCL13, IGKC, CD21) as well as immunosuppressive factors (IDO1, PD-1, PD-L1, CTLA4, FOXP3) was measured in 481 tumors. Results Increased levels of stromal TILs predicted pCR in univariable (P < .001) and multivariable analyses (P < .001). pCR rate was 59.9% in LPBC and 33.8% for non-LPBC (P < .001). pCR rates ≥ 75% were observed in patients with LPBC tumors treated with PMCb, with a significant test for interaction with therapy in the complete (P = .002) and HER2-positive (P = .006), but not the TNBC, cohorts. Hierarchic clustering of mRNA markers revealed three immune subtypes with different pCR rates (P < .001). All 12 immune mRNA markers were predictive for increased pCR. The highest odds ratios (ORs) were observed for PD-L1 (OR, 1.57; 95% CI, 1.34 to 1.86; P < .001) and CCL5 (OR, 1.41; 95% CI, 1.23 to 1.62; P < .001). Conclusion Immunologic factors were highly significant predictors of therapy response in the GeparSixto trial, particularly in patients treated with Cb. After further standardization, they could be included in histopathologic assessment of BC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
MillieWang完成签到,获得积分10
1秒前
干净的夜天完成签到 ,获得积分10
1秒前
1秒前
zo完成签到,获得积分20
1秒前
范特西发布了新的文献求助10
2秒前
2秒前
4秒前
4秒前
CodeCraft的应助被li采纳,获得10
5秒前
远了个方发布了新的文献求助10
5秒前
远了个方发布了新的文献求助10
5秒前
远了个方发布了新的文献求助10
5秒前
6秒前
june的应助被胡萝卜卜采纳,获得10
6秒前
miao完成签到 ,获得积分10
8秒前
8秒前
仁爱的沁发布了新的文献求助10
9秒前
搞怪的老九的应助被沃柑采纳,获得10
11秒前
12秒前
Rina发布了新的文献求助10
12秒前
12秒前
czy完成签到,获得积分10
12秒前
余香的应助被zhangzhen采纳,获得10
13秒前
st5114发布了新的文献求助10
13秒前
斯文败类的应助被茅文荣采纳,获得10
13秒前
14秒前
悠木完成签到 ,获得积分0
14秒前
zy发布了新的文献求助10
14秒前
14秒前
科研通AI65的应助被别哭还有我采纳,获得10
15秒前
舒适鸣凤的应助被灰焦炭采纳,获得10
15秒前
peiyu完成签到,获得积分10
15秒前
16秒前
16秒前
16秒前
慕青的应助被ri_290采纳,获得10
16秒前
16秒前
zhl完成签到,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193079
求助须知:如何正确求助?哪些是违规求助? 9579384
关于积分的说明 21865064
捐赠科研通 7792635
什么是DOI,文献DOI怎么找? 3437158
关于科研通互助平台的介绍 2560661
邀请新用户注册赠送积分活动 2483960